MUCOSTA Tablet Ref.[50979] Active ingredients: Rebamipide

Source: Web Search  Publisher: Manufactured By: Korea Otsuka Pharmaceutical Co., Ltd., Gyeonggi-do, Korea Under Authority of: Otsuka Pharmaceutical Co., Ltd., Japan Marketed By: Otsuka Pakistan Limited (A company of Otsuka Group Japan) ...

4.1. Therapeutic indications

  • Gastric ulcers.
  • Treatment of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions; acute gastritis and acute exacerbation of chronic gastritis.

4.2. Posology and method of administration

Gastric ulcers: The usual adult dosage of rebamipide is 100 mg (1 MUCOSTA Tablet) taken by the oral route three times daily, in the morning, in the evening, and before at bedtime.

Treatment of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions; acute gastritis and acute exacerbation of chronic gastritis: The usual adult dosage of rebamipide is 100 mg (1 MUCOSTA Tablet) three times daily taken by the oral route.

6.4. Special precautions for storage

Store below 30°C.

Keep all medicines out of the reach of children.

To be sold on the prescription of a registered medical practitioner only.

6.5. Nature and contents of container

Mucosta tablets are round, white, film coated tablets, with a code OG33 and supplied as 100mg tablets in packs of 100 tablets (blister strips of 10 × 10).

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.